09 decembrie 2021

Pharma lobby eyes parliamentarian

thehill.com

The pharmaceutical industry is banking on arcane Senate rules as a final plan of attack to unravel Democrats’ proposal to regulate prescription drug prices. In addition to their usual flurry of lobbying — which centers around blaming other sections of the health care system for rising costs — drugmakers are assisting Republican senators as they argue before Senate Parliamentarian Elizabeth MacDonough that drug price controls cannot be included in Democrats’ $2 trillion climate and social [...]